07 Feb 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Medizone International, developers of AsepticSure, a unique room disinfection system, has been granted a patent in Singapore for its international award-winning technology.
"This is our first patent grant for the Asian market. As reported by Asiaone, your Health, Singapore saw an estimated 850,000 foreign patients in 2012 with estimated revenues from medical tourism of $3.5 billion. The medical tourism growth rate is projected to be 15 to 20 percent annually through 2015," said Mr Edwin Marshall, CEO, Medizone. "Preliminary market research in Asia has confirmed that many leading hospitals in the medical tourism market will welcome AsepticSure as a key component to offering the safest hospitals possible, and to ensuring their future growth in this lucrative market."
Plans for a staged launch of AsepticSure into Asia are in the early development phase. Medizone has also made national filings of its health care application in South Korea, Japan, China, India, the US, Mexico, Brazil and the European Union.
These filings were made following release of a favorable report of the International Preliminary Examination Authority in the International stage of the patent application process.